Results 1 to 10 of about 42,096 (271)

Mast cell mediators in hereditary angioedema [PDF]

open access: yesOrphanet Journal of Rare Diseases
Background Bradykinin-mediated hereditary angioedema due to C1 inhibitor deficiency (HAE-C1INH) is often hard to differentiate from mast cell (MC) mediated diseases.
Hanga Réka Horváth   +4 more
doaj   +2 more sources

Heterogeneity in clinical appearance of chronic spontaneous urticaria: A cross-sectional analysis of a retrospective cohort [PDF]

open access: yesWorld Allergy Organization Journal
Aim: The study aimed to analyse the characteristics of subtypes of chronic spontaneous urticaria (CSU) and determine the factors that may influence treatment response. Methods: Clinical and laboratory characteristics of CSU patients were compared between
İlkim Deniz Toprak, MD   +9 more
doaj   +2 more sources

Inhibiting Plasma Kallikrein for Hereditary Angioedema Prophylaxis [PDF]

open access: yesNew England Journal of Medicine, 2017
Aleena Banerji   +2 more
exaly   +3 more sources

Acquired Angioedema Due to C1 inhibitor Deficiency Caused by Non-Hodgkin Lymphoma in a Patient with Myasthenia Gravis

open access: yesRomanian Journal of Laboratory Medicine, 2021
Acquired angioedema due to C1-inhibitor deficiency is a very rare disorder that usually appears in patients with lymphoproliferative and/or autoimmune diseases.
Bara Noémi   +3 more
doaj   +1 more source

The analysis of the effect of the COVID-19 pandemic on patients with hereditary angioedema type I and type II

open access: yesScientific Reports, 2023
Due to the similarity between the pathomechanism of SARS-CoV-2 infections and hereditary angioedema due to C1-inhibitor deficiency (C1-INH-HAE), a possibility emerged that C1-INH-HAE may worsen the course of the infection, or that the infection may ...
Dávid Szilágyi   +5 more
doaj   +1 more source

A clinical pathway for the diagnosis of sesame allergy in children

open access: yesWorld Allergy Organization Journal, 2022
Background: Sesame allergy (SA) is a common cause of life-threatening, persistent food allergy, not only in the Middle East and Asia, but increasingly worldwide. Commercially available tests such as extracts for skin testing or specific IgE for sesame or
Diti Machnes-Maayan, MD   +7 more
doaj   +1 more source

Late Hypersensitivity Reactions to the BNT162b2 SARS-CoV-2 Vaccine Are Linked to Delayed Skin Sensitization and Prior Exposure to Hyaluronic Acid

open access: yesLife, 2022
Background: Late hypersensitivity reactions (HSRs) to the BNT162b2-vaccine have raised concerns regarding its safety, particularly as further immunizations are required. The yield of skin testing with the BNT162b2v is unclear, as well as the risk factors
Ramit Maoz-Segal   +7 more
doaj   +1 more source

Long term follow-up of complement parameters to improve the management of acquired angioedema due to C1-inhibitor deficiency

open access: yesHeliyon, 2022
Acquired angioedema due to C1-inhibitor deficiency (C1–INH-AAE) is a rare disease that can be diagnosed via complement testing. It often accompanies lymphoproliferative underlying diseases.
Zsofia Polai   +4 more
doaj   +1 more source

Attenuated androgen discontinuation in patients with hereditary angioedema: a commented case series

open access: yesAllergy, Asthma & Clinical Immunology, 2022
Background Hereditary angioedema (HAE) is characterized by potentially severe and life-threatening attacks of localized swelling. Prophylactic therapies are available, including attenuated androgens. Efficacy of attenuated androgens has not been assessed
Marcus Maurer   +11 more
doaj   +1 more source

The characteristics of upper airway edema in hereditary and acquired angioedema with C1‐inhibitor deficiency

open access: yesClinical and Translational Allergy, 2021
Background Angioedemas localized in the upper airway are potentially life threatening, and without proper treatment, they may lead to death by suffocation. Upper airway edemas (UAE) in bradykinin‐mediated angioedemas can even be the first symptoms of the
Zsuzsanna Balla   +8 more
doaj   +1 more source

Home - About - Disclaimer - Privacy